| Pathogenic germline variants in cancer susceptibility genes in children and young adults with rhabdomyosarcoma J Kim*, N Light*, V Subasri*, EL Young*, T Wegman-Ostrosky, ... JCO Precision Oncology 5, 75-87, 2021 | 35 | 2021 |
| Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis N Light, M Layeghifard, A Attery, V Subasri, M Zatzman, ND Anderson, ... Nature Communications 14 (1), 77, 2023 | 12 | 2023 |
| Early Cancer Detection in Li–Fraumeni Syndrome with Cell-Free DNA D Wong, P Luo, LE Oldfield, H Gong, L Brunga, R Rabinowicz, V Subasri, ... Cancer Discovery 14 (1), 104-119, 2024 | 6 | 2024 |
| CyclOps: Cyclical development towards operationalizing ML models for health A Krishnan, V Subasri, K McKeen, A Kore, F Ogidi, M Alinoori, A Verma, ... medRxiv, 2022 | 4 | 2022 |
| Diagnosing and remediating harmful data shifts for the responsible deployment of clinical AI models V Subasri, A Krishnan, A Dhalla, D Pandya, D Malkin, F Razak, AA Verma, ... medRxiv, 2023.03. 26.23286718, 2023 | 3 | 2023 |
| Integrated analysis of cell-free DNA for the early detection of cancer in people with Li-Fraumeni Syndrome D Wong, P Luo, L Oldfield, H Gong, L Brunga, R Rabinowicz, V Subasri, ... medRxiv, 2022.10. 07.22280848, 2022 | 3 | 2022 |
| Multiple germline events contribute to cancer development in patients with Li-Fraumeni syndrome V Subasri, N Light, N Kanwar, J Brzezinski, P Luo, JR Hansford, ... Cancer research communications 3 (5), 738-754, 2023 | 1 | 2023 |
| CyclOps: a unified framework for data extraction and rigorous evaluation of ML models for clinical use-cases V Subasri, A Krishnan, YS Kaden McKeen, M Koshkina, N Lalani, ... Machine Learning for Healthcare, 2022 | 1 | 2022 |
| Horvath clock as a predictor of cancer risk in LFS patients M Pienkowska, N Samuel, S Choufani, V Subasri, N Patel, R Weksberg, ... Cancer Research 81 (13_Supplement), 2114-2114, 2021 | 1 | 2021 |
| Genomic and clinical characterization of a familial GIST kindred intolerant to imatinib KM Ingley, M Zatzman, AM Fontebasso, W Lo, V Subasri, A Goldenberg, ... NPJ Genomic Medicine 9 (1), 24, 2024 | | 2024 |
| Empirical data drift detection experiments on real-world medical imaging data A Kore, E Abbasi Bavil, V Subasri, M Abdalla, B Fine, E Dolatabadi, ... Nature Communications 15 (1), 1887, 2024 | | 2024 |
| DNA-Diffusion: Leveraging Generative Models for Controlling Chromatin Accessibility and Gene Expression via Synthetic Regulatory Elements L Ferreira DaSilva, S Senan, ZM Patel, AJ Reddy, S Gabbita, Z Nussbaum, ... bioRxiv, 2024.02. 01.578352, 2024 | | 2024 |
| MLHOps: Machine Learning for Healthcare Operations FK Khattak, V Subasri, A Krishnan, E Dolatabadi, D Pandya, ... arXiv preprint arXiv:2305.02474, 2023 | | 2023 |
| Investigating secondary findings in a pediatric cancer cohort: preliminary findings S Majeed, S Prokopec, B Laverty, V Subasri, M Taylor, Y Bombard, ... Cancer Research 83 (7_Supplement), 6545-6545, 2023 | | 2023 |
| DNA methylation predicts early onset of primary tumor in patients with Li-Fraumeni syndrome V Subasri, B Brew, L Erdman, T Guha, JR Hansford, E Cairney, ... Cancer Research 82 (12_Supplement), 1428-1428, 2022 | | 2022 |
| Diagnosing Li-Fraumeni syndrome from the somatic genome B Laverty, V Subasri, N Light, D Malkin Cancer Research 82 (12_Supplement), 3364-3364, 2022 | | 2022 |
| Multi-omic analysis of circulating tumour DNA for the early detection of cancer in patients with Li-Fraumeni syndrome D Wong, N Znassi, P Luo, LE Oldfield, J Bruce, A Danesh, S Prokopec, ... American College of Medical Genetics 24 (3), S346-S347, 2022 | | 2022 |
| Novel strategies for early cancer detection and prevention: The Li-Fraumeni syndrome story D Malkin, N Light, V Subasri, B Brew, S Paramathas, A Nabbi, ... American Association for Cancer Research 80 (14 Supplement), IA02-IA02, 2020 | | 2020 |
| Predictive modeling of cancer-type in Li-Fraumeni syndrome V Subasri, N Light, B Brew, N Anderson, A Shlien, A Goldenberg, ... Cancer Research 79 (13_Supplement), 1639-1639, 2019 | | 2019 |
| The genomic landscape and clonal evolution of tumours arising in TP53 mutation carriers N Light, M Zatzman, N Anderson, V Subasri, M Layeghifard, A Novokmet, ... Cancer Research 79 (13_Supplement), 3666-3666, 2019 | | 2019 |
David MalkinThe Hospital for Sick ChildrenVerified email at sickkids.ca
